We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China to Reform Oversight of Drug Prices, GMP Compliance
China to Reform Oversight of Drug Prices, GMP Compliance
China’s State Council is ordering the China Food and Drug Administration, and other agencies, to implement stricter policies to reform the country’s regulation of drug prices, GMP compliance and pharmaceutical marketing.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor